/
DCF Valuation
Base-case fair value
$3.90
Intrinsic $5.20 · 25% MOS
Current price: $35.47
Base-case summary
Our base-case DCF for Hims & Hers Health, Inc. (HIMS) projects 10 years of free cash flow growth at 8.7% for years 1–5 and 4.4% for years 6–10, anchored to 8.7% historical FCF growth, then applies a 2.5% perpetual growth rate and a 8.0% discount rate. Starting from $60M in trailing free cash flow, this produces an intrinsic value of $5.20 per share. A 25% safety margin gives a fair value of $3.90, suggesting the stock is currently 89% overvalued against the $35.47 market price.
See 3 scenarios side by side
Conservative, Base, and Optimistic fair values, plus the sensitivity matrix and FCF history. Free account.
Model inputs
TTM Free Cash Flow
$60M
Cash & equivalents
$751M
Total debt
$1.1B
Shares outstanding
228M